The genome landscape of ERα- and ERβ-binding DNA regions
- Yawen Liu*,†,
- Hui Gao*,
- Troels Torben Marstrand‡,
- Anders Ström*,
- Eivind Valen‡,
- Albin Sandelin‡,§,
- Jan-Åke Gustafsson*,§, and
- Karin Dahlman-Wright*
- *Department of Biosciences and Nutrition, Karolinska Institutet, Novum, SE-14157 Huddinge, Sweden;
- †Department of Epidemiology, School of Public Health, Jilin University, Changchun 130021, People's Republic of China; and
- ‡Bioinformatics Centre, Department of Biology and Biotech Research and Innovation Centre, University of Copenhagen, Ole Maaløes Vej 5, DK-2200 Copenhagen N, Denmark
-
Contributed by Jan-Åke Gustafsson, December 22, 2007 (received for review December 17, 2007)
Abstract
In this article, we have applied the ChIP-on-chip approach to pursue a large scale identification of ERα- and ERβ-binding DNA regions in intact chromatin. We show that there is a high degree of overlap between the regions identified as bound by ERα and ERβ, respectively, but there are also regions that are bound by ERα only in the presence of ERβ, as well as regions that are selectively bound by either receptor. Analysis of bound regions shows that regions bound by ERα have distinct properties in terms of genome landscape, sequence features, and conservation compared with regions that are bound by ERβ. ERβ-bound regions are, as a group, located more closely to transcription start sites. ERα- and ERβ-bound regions differ in sequence properties, with ERα-bound regions having an overrepresentation of TA-rich motifs including forkhead binding sites and ERβ-bound regions having a predominance of classical estrogen response elements (EREs) and GC-rich motifs. Differences in the properties of ER bound regions might explain some of the differences in gene expression programs and physiological effects shown by the respective estrogen receptors.
Footnotes
- §To whom correspondence may be adressed. E-mail: jan-ake.gustafsson{at}mednut.ki.se or albin{at}binf.ku.dk
-
Author contributions: Y.L., H.G., A. Sandelin, J.-Å.G., and K.D.-W. designed research; Y.L. performed research; A. Ström contributed new reagents/analytic tools; Y.L., H.G., T.T.M., E.V., A. Sandelin, and K.D.-W. analyzed data; and Y.L., T.T.M., A. Sandelin, J.-Å.G., and K.D.-W. wrote the paper.
-
Conflict of interest statement: J.-Å.G. is shareholder, research grant receiver, and consultant of KaroBio AB.
-
This article contains supporting information online at www.pnas.org/cgi/content/full/0712085105/DC1.
- © 2008 by The National Academy of Sciences of the USA





